APPLICATION
NDA021425
TYPE
NDA
ORIGINAL APPROVAL
2002-09-20
LATEST ACTION
2023-06-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription, Discontinued
Products
ULTRAVIST (PHARMACY BULK) · ReferencePrescription
IOPROMIDE 62.3% · INJECTABLE · INJECTION
ULTRAVIST (PHARMACY BULK) · ReferencePrescription
IOPROMIDE 76.9% · INJECTABLE · INJECTION
ULTRAVIST (PHARMACY BULK) · ReferenceDiscontinued
IOPROMIDE 49.9% · INJECTABLE · INJECTION
Approval history
2016-11-17Manufacturing (CMC) · Supplement 25 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.